The Hindu Business Line : Dr Reddy’s arm launches dermatology product in US

Hyderabad, Oct. 14 Promius Pharma LLC, a wholly owned subsidiary of pharma major Dr Reddy’s Laboratories Ltd, has launched its first product, EpiCeram Skin Barrier Emulsion, in the US market.

EpiCeram is a novel prescription therapy for the treatment of atopic dermatitis, a skin disease that affects more than 15 million people in the US.

Promius Pharma would formally launch the product at the 27th Annual Fall Clinical Dermatology Conference in Las Vegas, US which will be attended by over 400 dermatologists and healthcare providers.

Related Stories:
Betapharm losses drag Dr Reddy’s Q4 net down 68%
Dr Reddy’s net down 26% at Rs 134 cr
Dr Reddy’s launches subsidiary in US

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Dr Reddy’s arm launches dermatology product in US

Zydus vaccine gets WHO nod

Ranbaxy-Daiichi Sankyo deal to be completed by Dec

Buy gives Tata Motors electric vehicles tech prowess

Tata Motors buys majority stake in Norwegian firm

GMR acquires 50% in InterGen

NDTV Lumière offers world movies on a platter

Jet-Kingfisher deal: May not boost pricing power

Alliance will ‘ensure realistic fares’: Paramount

Tie-up could reduce overcapacity in the sector

Kingfisher-Jet alliance to improve the duo’s margins

Gujarat NRE Coke’s Australian arm on growth track

Abmak service apartments in Thrissur

GE gears up for civil nuclear play